Brief: Zentalis Pharmaceuticals Announces Pricing Of Underwritten Offering Of Common Stock
15/06/2023 11:06
June 15 (Reuters) - Zentalis Pharmaceuticals Inc
ZNTL.O :
* ZENTALIS PHARMACEUTICALS ANNOUNCES PRICING OF UNDERWRITTEN
OFFERING OF COMMON STOCK
* ZENTALIS PHARMACEUTICALS INC SAYS OFFERING OF 11.03
MILLION
COMMON SHARES PRICED AT $22.66PER SHARE
* ZENTALIS PHARMACEUTICALS INC - OFFERING IS EXPECTED TO
CLOSE ON
JUNE 20, 2023, SUBJECT TO CUSTOMARY CLOSING CONDITIONS
Source text for Eikon: ID:nGNX5pXLrV
Further company coverage: ZNTL.O
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer